CareDx to Participate in the Cantor Fitzgerald Global Healthcare Conference
Get Alerts CDNA Hot Sheet
Join SI Premium – FREE
BRISBANE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in the Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 2nd at 2:25 PM ET.
A live audio webcast of the Cantor Fitzgerald Global Healthcare Conference presentation will be available online from the investor relations section of the CareDx website at https://investors.caredxinc.com or through the following link http://wsw.com/webcast/cantor10/cdna/. The webcast replay of the presentation will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days.
About CareDx CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
For more information, please visit: www.CareDx.com.
CONTACTS:
Sasha KingChief Marketing Officer, CareDx Inc.415-287-2393[email protected]
Michael BellChief Financial Officer, CareDx Inc.415-287-2324 [email protected]
Source: CareDx, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Purpose Investments Inc. Announces 2026 Third Quarter Distributions for Purpose Specialty Lending Trust
- Royce Micro-Cap Trust (NYSE: RMT) as of Aug 31, 2026
- MacKenzie Realty Capital Reports FY 2026 Financial Results and Announces Suspension of Preferred Share Repurchase Program while Exploring Strategic Transactions
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share